fda warning letter hims & hers compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Hims cancels plans to sell

Doctor-prescribed compounded Tirzepatide dual GLP-1 & GIP agonist therapy for stronger appetite control and meaningful weight loss with once-weekly injections

Under the if-all-adhere estimand, CagriSema produced 23.0% weight loss at 84 weeks, against 25.5% for tirzepatide

The effects of GLP-1 infusion have also been studied on animal models of arrhythmias

So much for the easy fix heres what often comes with it: Physical setbacks like nausea, bloating, fatigue, and digestive discomfort quietly test the bodys tolerance

Leading Manufacturers of Commercial Kitchen Equipment Delivering innovative, durable, and high-performance kitchen solutions trusted by hotels, restaurants, and catering businesses since 1996

I also realized that it's okay to look for answers outside of the standard health system